Everis Medical acquires E Benson Hood Laboratories

Everis Medical has acquired Hood Laboratories, a Massachusetts-based medical technology company, in an effort to enhance its portfolio in the Otolaryngology, Head & Neck Surgery, and airway management domains. This acquisition aligns with Everis Medical’s strategy to broaden its market presence, adding to its existing array of medical devices used in ENT and thoracic procedures.

Hood Laboratories, established in 1962, is known for its specialized products including T-Tubes for tracheal stenosis treatment. These products are utilized across various specializations, such as laryngology, rhinology, thoracic surgery, and interventional pulmonology. This acquisition marks Everis Medical’s fifth strategic purchase since its inception in 2019. The specific financial terms of the deal remain undisclosed.

The transaction is a continuation of Everis Medical’s aggressive expansion strategy in the Otolaryngology/Head and Neck Surgery market. The company has previously acquired four notable entities, including the Cook Medical Otolaryngology/Head and Neck Surgery products and Shaw Scalpel from Hemostatix. These acquisitions collectively enhance Everis Medical's capability to offer comprehensive solutions covering diagnosis, intervention, and post-operative care.

For the broader medical technology sector, this acquisition reflects a trend toward consolidation as companies aim to diversify their product offerings and leverage synergies in specialized markets. The transaction enables Everis Medical to fortify its competitive edge in airway and ENT management technologies. It also suggests increased competition for market share in these niches, posing challenges to smaller specialized manufacturers.

With executives experienced in the medical device sector and backed by Shore Capital Partners, Everis Medical is poised to integrate Hood Laboratories’ operations seamlessly, ensuring continuity of service and product availability. This integration is expected to provide a robust foundation for potential future expansions and innovations, while maintaining their focus on improving patient outcomes.